| Serial Number | 79412324 |
| Word Mark | KOJOX |
| Filing Date | Wednesday, August 28, 2024 |
| Status | 680 - APPROVED FOR PUBLICATION |
| Status Date | Friday, August 8, 2025 |
| Registration Number | 0000000 |
| Registration Date | NOT AVAILABLE |
| Mark Drawing | 5 - Drawing with word(s) / letter(s) / number(s) in Stylized form |
| Published for Opposition Date | NOT AVAILABLE |
| Goods and Services | Custom processing and manufacturing of biopharmaceuticals; custom processing and manufacturing of pharmaceuticals; custom manufacture of pharmaceuticals; manufacture, processing and production of recombinant proteins for use in the biotechnology industries to the order and specification of others; cell culture manufacturing services for others; custom manufacture of biologics; information, advice and consultancy in relation to all the aforesaid |
| Goods and Services | Scientific and technological services, namely, scientific research, analysis and testing in the fields of biotechnology, biologics, biopharmaceuticals and pharmaceuticals; research and development in the fields of biotechnology, biologics, biopharmaceuticals and pharmaceuticals; scientific analysis in the fields of biotechnology, biologics, biopharmaceuticals and pharmaceuticals; industrial and technical research, development and analysis services; scientific, industrial process development in the fields of biotechnology, biologics, biopharmaceuticals and pharmaceuticals; development of processes for the use and manufacture of biotechnology products; technical project studies in the fields of biotechnology, biologics, biopharmaceuticals and pharmaceuticals; industrial process development in the fields of biotechnology, biologics, biopharmaceuticals and pharmaceuticals; development of processes for the use in the manufacture of biotechnology products; biotechnology product testing services; research and consultancy in the field of biotechnology; research and development in the pharmaceutical and biotechnology industry; scientific, technological and pharmaceutical process development and design in the fields of biotechnology, biologics, biopharmaceuticals and pharmaceuticals; biopharmaceutical product development; computer software development, programming and implementation for others; design and development of computer software; design and development of manufacturing processes in the field of biopharmaceuticals; design of manufacturing methods; design of industrial buildings; design of manufacturing plants; engineering services in the fields of biotechnology, biologics, biopharmaceuticals and pharmaceuticals; medical and biological research laboratory services; preparation of biological samples for analysis in research laboratories; development of processes for use in the manufacture of products in the biotechnology industry; design services relating to manufacturing plants for the biotechnology industry; information, advice and consultancy in relation to all the aforesaid |
| International Class | 040 - Treatment of materials. |
| US Class Codes | 100, 103, 106 |
| Class Status Code | 6 - Active |
| Class Status Date | Thursday, December 19, 2024 |
| Primary Code | 040 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| International Class | 042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software. |
| US Class Codes | 100, 101 |
| Class Status Code | 6 - Active |
| Class Status Date | Thursday, December 19, 2024 |
| Primary Code | 042 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| Party Name | FUJIFILM Diosynth Biotechnologies UK Limited |
| Party Type | 10 - Original Applicant |
| Legal Entity Type | 99 - Other |
| Address | GB |
| Event Date | Event Description |
| Thursday, December 19, 2024 | SN ASSIGNED FOR SECT 66A APPL FROM IB |
| Tuesday, March 4, 2025 | ASSIGNED TO EXAMINER |
| Thursday, March 6, 2025 | NON-FINAL ACTION WRITTEN |
| Friday, March 7, 2025 | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW |
| Monday, December 23, 2024 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED |
| Monday, December 23, 2024 | APPLICATION FILING RECEIPT MAILED |
| Wednesday, March 12, 2025 | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED |
| Wednesday, March 12, 2025 | APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED |
| Wednesday, March 12, 2025 | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED |
| Wednesday, March 12, 2025 | TEAS CHANGE OF OWNER ADDRESS RECEIVED |
| Tuesday, April 15, 2025 | REFUSAL PROCESSED BY MPU |
| Tuesday, April 15, 2025 | NON-FINAL ACTION MAILED - REFUSAL SENT TO IB |
| Wednesday, July 16, 2025 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
| Wednesday, July 16, 2025 | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
| Friday, August 8, 2025 | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED |
| Friday, August 8, 2025 | EXAMINER'S AMENDMENT ENTERED |
| Friday, August 8, 2025 | EXAMINERS AMENDMENT E-MAILED |
| Friday, August 8, 2025 | EXAMINERS AMENDMENT -WRITTEN |
| Friday, August 8, 2025 | APPROVED FOR PUB - PRINCIPAL REGISTER |
| Thursday, July 17, 2025 | TEAS/EMAIL CORRESPONDENCE ENTERED |
| Sunday, May 4, 2025 | REFUSAL PROCESSED BY IB |